drugset
Drugs / pooled human immunoglobulin
last change Oct 2025 re-read 3 minutes ago

pooled human immunoglobulin

also known as IVIG

Protein / enzyme biologic

Developed for
immune-mediated necrotizing myopathy
Investigated by
CSI Pharmacy · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Octapharma USA, Inc. · University of Alabama at Birmingham

Trials 1

today NCT06599697 · Ph 2
20262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT06599697 Oct 2025 → Dec 2026 expected immune-mediated necrotizing myopathy University of Alabama at Birmingham Recruiting No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as pooled human immunoglobulin ClinicalTrials.gov intervention name — accepted as the source's own label NCT06599697 ↗
Known as IVIG “Intravenously administered pooled human immunoglobulin (IVIG)” NCT06599697 ↗
Modality Protein / enzyme biologic “pooled human immunoglobulin” NCT06599697 ↗
Route Intravenous “intravenously administered pooled human immunoglobulin (IVIG)” NCT06599697 ↗